Nothing Special   »   [go: up one dir, main page]

Mari et al., 2002 - Google Patents

Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects

Mari et al., 2002

View HTML @Full View
Document ID
14899007795255267074
Author
Mari A
Schmitz O
Gastaldelli A
Oestergaard T
Nyholm B
Ferrannini E
Publication year
Publication venue
American Journal of Physiology-Endocrinology and Metabolism

External Links

Snippet

We investigated β-cell function and its relationship to insulin sensitivity in 17 normal volunteers. For insulin secretion (derived by C-peptide deconvolution), a mathematical model was applied to 24-h triple-meal tests (MT) as well as oral glucose tolerance tests …
Continue reading at journals.physiology.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Mari et al. Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects
Santilli et al. Effects of liraglutide on weight loss, fat distribution, and β-cell function in obese subjects with prediabetes or early type 2 diabetes
Cobelli et al. Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests
Guldstrand et al. Improved β-cell function after standardized weight reduction in severely obese subjects
Chang et al. Aging and insulin secretion
Zeitler et al. Type 2 diabetes in the child and adolescent.
de Boer et al. Impaired glucose and insulin homeostasis in moderate-severe CKD
Salehi et al. Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes
Malin et al. Pancreatic β-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes
Muscelli et al. Impact of incretin hormones on β-cell function in subjects with normal or impaired glucose tolerance
Abdul-Ghani et al. The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance
Gutzwiller et al. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
Yabe et al. Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients
Solomon et al. Improved pancreatic β-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide
Basu et al. Both fasting glucose production and disappearance are abnormal in people with “mild” and “severe” type 2 diabetes
Miyazaki et al. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus
Milner et al. Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance
Hahn et al. Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls
Kato et al. Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes
Boey et al. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes
Nannipieri et al. Risk factors for spontaneously self-reported postprandial hypoglycemia after bariatric surgery
Vella et al. The effect of dipeptidyl peptidase‐4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double‐blind, placebo‐controlled crossover study
Lovshin et al. Blood pressure-lowering effects of incretin-based diabetes therapies
Chan et al. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes
Jensen et al. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery